Helping biotech startups and life sciences innovators grow strategically, build partnerships, and successfully bring their products to market, ensuring effective commercialisation, adoption, early stakeholder engagement, and sustainable competitive advantage in evolving global biotech innovation sectors.
Guiding early-stage biotech companies through seed, Series A, and strategic investments, including pitch deck preparation, investor targeting, funding strategy, comprehensive guidance, financial modelling, and practical advice to secure investment and attract long-term strategic stakeholders worldwide.
Reviewing and refining business plans, financial models, and go-to-market strategies to strengthen investor confidence, optimise growth, address operational challenges, enhance decision-making processes, and deliver actionable insights for long-term sustainable business success globally.
Assessing the technical, commercial, and financial feasibility of early-stage biotech projects to inform strategic decisions, investment readiness, value creation potential, realistic commercial opportunities, competitive positioning, and effective market entry planning strategies accurately.
Offering one-on-one mentorship, workshops, and guidance on leadership, operations, and growth management to equip biotech founders with practical skills, strategic know-how, decision-making confidence, and operational insights for successfully scaling their ventures internationally.
Advising on international market entry, regulatory considerations, strategic alliances, and operational scaling to help biotech startups grow globally, identify key opportunities, build strong partnerships, and maximise strategic impact across international biotech and life sciences ecosystems.
The Biotechnology Business Institute works in partnership and collaboartion with leading companies in the life sciences sector. Our partners will provide impartial assessment and will help you to achieve your goals at any stage that your company is in to develop your business. Contact us for more information.
Here are some of the most frequent questions from our candidates
With a presence in two of the main innovation centres in Europe, Barcelona, and Cambridge, and the second largest market in the pharmaceutical industry in Latin America our students can choose which campus will best meet their needs.
As the International BBI headquarters, the Barcelona Campus is focused on drug discovery, built on a track record since 2013 delivering management programmes for scientists wanting to develop their careers in the global pharma & biotechnology industry.
The European headquarters, our Cambridge Campus, has a broader remit across the entire Life Science sector. At Cambridge, UK, our students can realise their objective of establishing a global network of contacts in the broader spectrum of commercial opportunities in Life Sciences.
BBI Mexico connects the pharmaceutical and biotechnology industry in Latin America with the major innovation hubs in Europe and the United States. It is the educational centre of reference in healthcare contributing to the development of national talent and the growth of national innovation promoting global transactions.
Know more about our campuses
The BBI Business School has over 140 academics and industry experts, coming from more than 20 countries, who cover the key management topics in the Life Sciences industry: corporate finance; market access and healthcare economics, preclinical and clinical regulatory requirements, medical technologies, technology transfer and entrepreneurship, organisational behaviour and an understanding of the global strategy for new drug approvals.
The Biotechnology Business Institute (BBI) is an international business school focused on training a new generation of scientific managers and executives to prepare for their future careers. The BBI facilitates early-stage business development activities in partnership with the many stakeholders in the biotechnology sector and the pharmaceutical industry worldwide. A core focus is on new drug development to treat unmet medical need but also with broadening interests across the Life Sciences sector.
The Biotechnology Business Institute was founded to develop the next generation of talent in the international Life Sciences sector for scientists seeking to advance their careers in the pharmaceutical and biotechnology industries. We are committed to becoming a leading international academic institution in the management of Life Sciences, through enabling the career development of a new wave of global business leaders driving disruptive change throughout the ecosystem.
The BBI network is formed by our alumni, the academic staff, lecturers, partner companies and the technology transfer offices who collaborate with us. Over the years, we have developed a community over 700 people globally in direct contact every year.
For more information, visit our BBI community Report